STONKWHISPER
← Back to Intel
Insider ActivityBBIO

Kumar Neil, Chief Executive Officer, Director at BridgeBio Pharma, Inc., sold $1.1M of BBIO

Updated Jun 19, 2026
Kumar Neil Chief Executive Officer, Director
BridgeBio Pharma, Inc. · $BBIO
$1.1M Total Value
15,921 Shares Traded
$67.7378 Price / Share
536,136 Shares Owned After
2026-06-08 Filing Date

Transaction Details

InsiderKumar Neil
TitleChief Executive Officer, Director
CompanyBridgeBio Pharma, Inc.
TickerBBIO
Transaction TypeSale
Transaction Date2026-06-04
Shares Traded15,921
Price Per Share$67.7378
Total Value$1.1M
Filed Date2026-06-08
Accession Number0001470831-26-000523

Ownership Context

Shares Owned After Transaction536,136
Ownership TypeIndirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001470831-26-000523

Other Insider Trades — BBIO

Other Trades by Kumar Neil

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for BBIO — BridgeBio Pharma, Inc. →

Track BBIO insider activity in real time on The Wire →

Get alerts when Kumar Neil files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:04 UTC

Want real-time data? Access The Wire for live sentiment tracking.